Clinical trial
Assessment Of Safety Of UK-390,957
NCT00219609 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00219609 |
|---|---|
| Title | Assessment Of Safety Of UK-390,957 |
| Official title | A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ejaculation |
| Intervention type | Drug |
| Interventions | UK-390, 957 |
| Enrollment | 1,058 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 7, 2012 |
| Countries | Australia, Austria, Canada, Czechia, France, Germany, Israel, Italy, Norway, Poland, Sweden, Turkey (Türkiye) and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: